1. Home
  2. NXPL vs UBX Comparison

NXPL vs UBX Comparison

Compare NXPL & UBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NXPL
  • UBX
  • Stock Information
  • Founded
  • NXPL 1997
  • UBX 2009
  • Country
  • NXPL United States
  • UBX United States
  • Employees
  • NXPL N/A
  • UBX N/A
  • Industry
  • NXPL Telecommunications Equipment
  • UBX Biotechnology: Pharmaceutical Preparations
  • Sector
  • NXPL Telecommunications
  • UBX Health Care
  • Exchange
  • NXPL Nasdaq
  • UBX Nasdaq
  • Market Cap
  • NXPL 12.4M
  • UBX 16.2M
  • IPO Year
  • NXPL N/A
  • UBX 2018
  • Fundamental
  • Price
  • NXPL $0.55
  • UBX $0.91
  • Analyst Decision
  • NXPL
  • UBX Strong Buy
  • Analyst Count
  • NXPL 0
  • UBX 3
  • Target Price
  • NXPL N/A
  • UBX $5.33
  • AVG Volume (30 Days)
  • NXPL 149.9K
  • UBX 106.2K
  • Earning Date
  • NXPL 05-15-2025
  • UBX 04-22-2025
  • Dividend Yield
  • NXPL N/A
  • UBX N/A
  • EPS Growth
  • NXPL N/A
  • UBX N/A
  • EPS
  • NXPL N/A
  • UBX N/A
  • Revenue
  • NXPL $65,483,000.00
  • UBX N/A
  • Revenue This Year
  • NXPL N/A
  • UBX N/A
  • Revenue Next Year
  • NXPL N/A
  • UBX N/A
  • P/E Ratio
  • NXPL N/A
  • UBX N/A
  • Revenue Growth
  • NXPL 73.44
  • UBX N/A
  • 52 Week Low
  • NXPL $0.43
  • UBX $0.85
  • 52 Week High
  • NXPL $2.30
  • UBX $3.10
  • Technical
  • Relative Strength Index (RSI)
  • NXPL 41.14
  • UBX 37.72
  • Support Level
  • NXPL $0.50
  • UBX $0.86
  • Resistance Level
  • NXPL $0.60
  • UBX $1.23
  • Average True Range (ATR)
  • NXPL 0.07
  • UBX 0.09
  • MACD
  • NXPL 0.01
  • UBX 0.01
  • Stochastic Oscillator
  • NXPL 30.81
  • UBX 14.62

About NXPL NextPlat Corp

NextPlat Corp is an e-commerce and healthcare company. Its e-commerce venues form an effective network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operates in two segments: e-Commerce Operations involves acquiring and leasing an e-commerce platform; and Healthcare Operations provides TPA, data management, COVID-19 related diagnostics and vaccinations, prescription pharmaceuticals, and Others.

About UBX Unity Biotechnology Inc.

Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone which is produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.

Share on Social Networks: